News and Events
Triology Longevity, a global leader of longevity and regenerative medicine in China.

China's longevity economy enters an explosive period

Release time:

2025.03.21


The 2024 China Longevity Economy White Paper indicates that the domestic longevity medicine and regenerative medicine market is developing rapidly. Government policy support and increased public health awareness have created enormous growth opportunities for the longevity medicine industry. By 2030, China is expected to become one of the largest longevity medicine markets in the world.
San Yi Changsheng Medical Group, seizing industry development trends, continues to lead the future development of longevity and regenerative medicine with innovative technologies and international cooperation, while helping global populations achieve the new goal of healthy longevity.